Myriad Genetics Inc (NASDAQ:MYGN)

19.47
Delayed Data
As of 4:00pm ET
 +1.26 / +6.92%
Today’s Change
16.02
Today|||52-Week Range
33.18
-29.46%
Year-to-Date

Today’s Trading

Previous close18.21
Today’s open18.52
Day’s range18.52 - 19.63
Volume32,940
Average volume (3 months)523,535
Market cap$1.5B
Data as of 4:00pm ET, 09/28/2022

Growth & Valuation

Earnings growth (last year)+87.01%
Earnings growth (this year)-362.50%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+8.14%
P/E ratioNM
Price/Sales3.12
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...+0.25+0.79%
CLDXCelldex Therapeutics...+1.01+3.63%
VCYTVeracyte Inc+0.44+2.60%
----
Data as of 4:00pm ET, 09/28/2022

Financials

Next reporting dateNovember 1, 2022
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$690.6M
Annual profit (last year)-$27.2M
Net profit margin-3.94%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts